Structure Therapeutics Inc. - GPCR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND L P | 2.6% | 5,583,855 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF I GP LLC | 2.6% | 5,583,855 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND II LP | 1.9% | 4,053,954 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF II GP LLC | 1.9% | 4,053,954 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Biotechnology Value Trading Fund OS LP | 0.3% | 643,536 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF Partners OS Ltd. | 0.3% | 643,536 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF GP HOLDINGS LLC | 4.5% | 9,637,809 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF PARTNERS L P/IL | 4.9% | 10,437,066 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF INC/IL | 4.9% | 10,437,066 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | LAMPERT MARK N | 4.9% | 10,437,066 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Deep Track Capital, LP | 5.95% | 12,335,346 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 5.95% | 12,335,346 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | David Kroin | 5.95% | 12,335,346 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Group LLP | 10.1% | 21,365,952 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 10.1% | 21,365,952 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 10.1% | 21,365,952 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Company LLP | 9.6% | 21,365,952 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 15.0% | 31,112,634 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 15.0% | 31,112,634 | View |
| Nov 14, 2025 | SCHEDULE 13G | Avoro Capital Advisors LLC | 9.38% | 16,216,665 | View |
| Nov 14, 2025 | SCHEDULE 13G | Aghazadeh Behzad | 9.38% | 16,216,665 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 7.7% | 4,448,826 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Capital, LP | 7.32% | 12,647,433 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 7.32% | 12,647,433 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | David Kroin | 7.32% | 12,647,433 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Management Group LLP | 11.9% | 20,631,498 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 11.9% | 20,631,498 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 11.9% | 20,631,498 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Management Company LLP | 11.5% | 20,631,498 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Management Group LLP | 9.9% | 17,067,561 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 9.9% | 17,067,561 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 9.9% | 17,067,561 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Management Company LLP | 9.5% | 17,067,561 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.